Published in Psychopharmacology (Berl) on April 05, 2014
Anticonvulsant effects of isomeric nonimidazole histamine H3 receptor antagonists. Drug Des Devel Ther (2016) 0.75
Neuroactive steroids. FASEB J (1992) 3.41
Antiepileptic drug development: II. Anticonvulsant drug screening. Epilepsia (1978) 1.82
Anticonvulsant activity of neurosteroids: correlation with gamma-aminobutyric acid-evoked chloride current potentiation. J Pharmacol Exp Ther (1994) 1.71
Conserved site for neurosteroid modulation of GABA A receptors. Neuropharmacology (2008) 1.56
Neurosteroids: endogenous allosteric modulators of GABA(A) receptors. Psychoneuroendocrinology (2009) 1.52
Stress-induced deoxycorticosterone-derived neurosteroids modulate GABA(A) receptor function and seizure susceptibility. J Neurosci (2002) 1.49
Enantioselectivity of steroid-induced gamma-aminobutyric acidA receptor modulation and anesthesia. Mol Pharmacol (1996) 1.35
Neurosteroid analogues. 12. Potent enhancement of GABA-mediated chloride currents at GABAA receptors by ent-androgens. Eur J Med Chem (2007) 1.31
Anticonvulsant activity of androsterone and etiocholanolone. Epilepsia (2005) 1.30
Characterization of steroid interactions with gamma-aminobutyric acid receptor-gated chloride ion channels: evidence for multiple steroid recognition sites. Mol Pharmacol (1990) 1.29
Enantioselectivity of pregnanolone-induced gamma-aminobutyric acid(A) receptor modulation and anesthesia. J Pharmacol Exp Ther (2000) 1.25
Allopregnanolone analogs that positively modulate GABA receptors protect against partial seizures induced by 6-Hz electrical stimulation in mice. Epilepsia (2004) 1.25
Progress report on new antiepileptic drugs: a summary of the Eleventh Eilat Conference (EILAT XI). Epilepsy Res (2012) 1.24
Finasteride, a 5alpha-reductase inhibitor, blocks the anticonvulsant activity of progesterone in mice. J Pharmacol Exp Ther (1999) 1.22
Steroid anesthetics and naturally occurring analogs modulate the gamma-aminobutyric acid receptor complex at a site distinct from barbiturates. J Pharmacol Exp Ther (1989) 1.18
ent-Steroids: novel tools for studies of signaling pathways. Steroids (2008) 1.12
Enhanced anticonvulsant activity of ganaxolone after neurosteroid withdrawal in a rat model of catamenial epilepsy. J Pharmacol Exp Ther (2000) 1.01
Conformationally constrained anesthetic steroids that modulate GABA(A) receptors. J Med Chem (2000) 0.98
Correlation of neuroactive steroid modulation of [35S]t-butylbicyclophosphorothionate and [3H]flunitrazepam binding and gamma-aminobutyric acidA receptor function. Mol Pharmacol (1994) 0.93
Neurosteroid analogues. 17. Inverted binding orientations of androsterone enantiomers at the steroid potentiation site on γ-aminobutyric acid type A receptors. J Med Chem (2012) 0.83
Stereoselectivity and affinity in molecular pharmacology. Prog Drug Res (1976) 0.78
TDP-43 regulates its mRNA levels through a negative feedback loop. EMBO J (2010) 2.90
Adjunctive perampanel for refractory partial-onset seizures: randomized phase III study 304. Neurology (2012) 2.36
The anticonvulsant activity of acetone, the major ketone body in the ketogenic diet, is not dependent on its metabolites acetol, 1,2-propanediol, methylglyoxal, or pyruvic acid. Epilepsia (2007) 2.20
Anticonvulsant medications extend worm life-span. Science (2005) 2.18
The transcription factor STAT-1 couples macrophage synthesis of 25-hydroxycholesterol to the interferon antiviral response. Immunity (2012) 1.96
Neurosteroid access to the GABAA receptor. J Neurosci (2005) 1.95
Molecular targets for antiepileptic drug development. Neurotherapeutics (2007) 1.78
Sterol intermediates from cholesterol biosynthetic pathway as liver X receptor ligands. J Biol Chem (2006) 1.72
Oxysterols are allosteric activators of the oncoprotein Smoothened. Nat Chem Biol (2012) 1.72
Neuroprotective and disease-modifying effects of the ketogenic diet. Behav Pharmacol (2006) 1.65
Pregnane X receptor (PXR) activation: a mechanism for neuroprotection in a mouse model of Niemann-Pick C disease. Proc Natl Acad Sci U S A (2006) 1.62
Adult murine skeletal muscle contains cells that can differentiate into beating cardiomyocytes in vitro. PLoS Biol (2005) 1.60
Mechanisms of neurosteroid interactions with GABA(A) receptors. Pharmacol Ther (2007) 1.60
Identification and characterization of cholest-4-en-3-one, oxime (TRO19622), a novel drug candidate for amyotrophic lateral sclerosis. J Pharmacol Exp Ther (2007) 1.55
The neuropharmacology of the ketogenic diet. Pediatr Neurol (2007) 1.54
Cholesterol depletion results in site-specific increases in epidermal growth factor receptor phosphorylation due to membrane level effects. Studies with cholesterol enantiomers. J Biol Chem (2003) 1.52
Stress-induced deoxycorticosterone-derived neurosteroids modulate GABA(A) receptor function and seizure susceptibility. J Neurosci (2002) 1.49
Glia and epilepsy: excitability and inflammation. Trends Neurosci (2013) 1.49
Neuroactive steroids have multiple actions to potentiate GABAA receptors. J Physiol (2004) 1.47
Mutations of the GABA-A receptor alpha1 subunit M1 domain reveal unexpected complexity for modulation by neuroactive steroids. Mol Pharmacol (2008) 1.46
Selective antagonism of GluR5 kainate-receptor-mediated synaptic currents by topiramate in rat basolateral amygdala neurons. J Neurosci (2003) 1.45
Withania somnifera: an Indian ginseng. Prog Neuropsychopharmacol Biol Psychiatry (2007) 1.44
Oxidative stress in NPC1 deficient cells: protective effect of allopregnanolone. J Cell Mol Med (2008) 1.33
Natural and enantiomeric etiocholanolone interact with distinct sites on the rat alpha1beta2gamma2L GABAA receptor. Mol Pharmacol (2007) 1.33
Autoregulation of TDP-43 mRNA levels involves interplay between transcription, splicing, and alternative polyA site selection. Genes Dev (2012) 1.33
Dual potentiating and inhibitory actions of a benz[e]indene neurosteroid analog on recombinant alpha1beta2gamma2 GABAA receptors. Mol Pharmacol (2006) 1.31
Neurosteroid analogues. 12. Potent enhancement of GABA-mediated chloride currents at GABAA receptors by ent-androgens. Eur J Med Chem (2007) 1.31
Anticonvulsant activity of androsterone and etiocholanolone. Epilepsia (2005) 1.30
Allopregnanolone analogs that positively modulate GABA receptors protect against partial seizures induced by 6-Hz electrical stimulation in mice. Epilepsia (2004) 1.25
Effects of natural and enantiomeric cholesterol on the thermotropic phase behavior and structure of egg sphingomyelin bilayer membranes. Biophys J (2003) 1.24
Slow actions of neuroactive steroids at GABAA receptors. J Neurosci (2004) 1.24
Selective antagonism of 5alpha-reduced neurosteroid effects at GABA(A) receptors. Mol Pharmacol (2004) 1.23
Endogenous neurosteroids modulate epileptogenesis in a model of temporal lobe epilepsy. Exp Neurol (2006) 1.23
Topiramate selectively protects against seizures induced by ATPA, a GluR5 kainate receptor agonist. Neuropharmacology (2004) 1.21
The sticky issue of neurosteroids and GABA(A) receptors. Trends Neurosci (2010) 1.21
Anxiolytic activity of progesterone in progesterone receptor knockout mice. Neuropharmacology (2005) 1.20
3beta -hydroxypregnane steroids are pregnenolone sulfate-like GABA(A) receptor antagonists. J Neurosci (2002) 1.18
Side chain oxygenated cholesterol regulates cellular cholesterol homeostasis through direct sterol-membrane interactions. J Biol Chem (2008) 1.17
Neuroprotective effects of an estratriene analog are estrogen receptor independent in vitro and in vivo. Brain Res (2005) 1.16
Clustered burst firing in FMR1 premutation hippocampal neurons: amelioration with allopregnanolone. Hum Mol Genet (2012) 1.15
Selective T-type calcium channel blockade alleviates hyperalgesia in ob/ob mice. Diabetes (2009) 1.15
Structure and function of the Smoothened extracellular domain in vertebrate Hedgehog signaling. Elife (2013) 1.15
The influence of neuroactive steroid lipophilicity on GABAA receptor modulation: evidence for a low-affinity interaction. J Neurophysiol (2009) 1.14
On the mechanism of antidepressant-like action of berberine chloride. Eur J Pharmacol (2008) 1.14
Berberine: a plant alkaloid with therapeutic potential for central nervous system disorders. Phytother Res (2010) 1.14
Neurosteroids, stress and depression: potential therapeutic opportunities. Neurosci Biobehav Rev (2012) 1.12
Energetics by NMR: site-specific binding in a positively cooperative system. Proc Natl Acad Sci U S A (2002) 1.11
Gastrointestinal absorption and plasma kinetics of soy Delta(5)-phytosterols and phytostanols in humans. Am J Physiol Endocrinol Metab (2002) 1.11
Estrogen-like compounds for ischemic neuroprotection. Stroke (2004) 1.10
First synthesis of ent-desmosterol and its conversion to ent-deuterocholesterol. Steroids (2003) 1.10
How theories evolved concerning the mechanism of action of barbiturates. Epilepsia (2012) 1.10
Neurosteroid replacement therapy for catamenial epilepsy. Neurotherapeutics (2009) 1.09
Ganaxolone suppression of behavioral and electrographic seizures in the mouse amygdala kindling model. Epilepsy Res (2010) 1.07
Neurosteroid migration to intracellular compartments reduces steroid concentration in the membrane and diminishes GABA-A receptor potentiation. J Physiol (2007) 1.07
Neuroprotective effects of 17beta-estradiol and nonfeminizing estrogens against H2O2 toxicity in human neuroblastoma SK-N-SH cells. Mol Pharmacol (2006) 1.06
Effect of various classes of antidepressants in behavioral paradigms of despair. Prog Neuropsychopharmacol Biol Psychiatry (2007) 1.06
Investigating the allosterism of acyl-CoA:cholesterol acyltransferase (ACAT) by using various sterols: in vitro and intact cell studies. Biochem J (2005) 1.06
Neurosteroid analog photolabeling of a site in the third transmembrane domain of the β3 subunit of the GABA(A) receptor. Mol Pharmacol (2012) 1.05
Neurosteroids enhance spontaneous glutamate release in hippocampal neurons. Possible role of metabotropic sigma1-like receptors. J Biol Chem (2002) 1.03
Anticonvulsant and anesthetic effects of a fluorescent neurosteroid analog activated by visible light. Nat Neurosci (2007) 1.03
GABAergic neurosteroids mediate the effects of ethanol on long-term potentiation in rat hippocampal slices. Eur J Neurosci (2007) 1.01
Characterization of enantiomeric bile acid-induced apoptosis in colon cancer cell lines. J Biol Chem (2008) 1.01
New strategies for the identification of drugs to prevent the development or progression of epilepsy. Epilepsy Res (2002) 1.01
Photoaffinity labeling with a neuroactive steroid analogue. 6-azi-pregnanolone labels voltage-dependent anion channel-1 in rat brain. J Biol Chem (2003) 1.01
Neuroprotective effects of a novel non-receptor-binding estrogen analogue: in vitro and in vivo analysis. Stroke (2002) 1.01
Neuroactive steroids and human recombinant rho1 GABAC receptors. J Pharmacol Exp Ther (2007) 1.00
Cerebellar ataxia, seizures, premature death, and cardiac abnormalities in mice with targeted disruption of the Cacna2d2 gene. Am J Pathol (2004) 1.00
Synthesis, characterization, and receptor interaction profiles of enantiomeric bile acids. J Med Chem (2007) 0.99
Neurosteroid analogues. 14. Alternative ring system scaffolds: GABA modulatory and anesthetic actions of cyclopenta[b]phenanthrenes and cyclopenta[b]anthracenes. J Med Chem (2008) 0.98
Potentials of curcumin as an antidepressant. ScientificWorldJournal (2009) 0.98
Relationship between phosphatidylinositol 4-phosphate synthesis, membrane organization, and lateral diffusion of PI4KIIalpha at the trans-Golgi network. J Lipid Res (2010) 0.98
Differential interaction of the two cholesterol-dependent, membrane-damaging toxins, streptolysin O and Vibrio cholerae cytolysin, with enantiomeric cholesterol. FEBS Lett (2003) 0.97
Total synthesis of ent-cholesterol via a steroid C,D-ring side-chain synthon. J Org Chem (2002) 0.97
Treatment of infantile spasms: emerging insights from clinical and basic science perspectives. J Child Neurol (2011) 0.97
Efficacy of the ketogenic diet in the 6-Hz seizure test. Epilepsia (2007) 0.96
Enantioselective protein-sterol interactions mediate regulation of both prokaryotic and eukaryotic inward rectifier K+ channels by cholesterol. PLoS One (2011) 0.96
RNA structure is a key regulatory element in pathological ATM and CFTR pseudoexon inclusion events. Nucleic Acids Res (2007) 0.96
Issues related to development of new antiseizure treatments. Epilepsia (2013) 0.96
Tetramethylenedisulfotetramine alters Ca²⁺ dynamics in cultured hippocampal neurons: mitigation by NMDA receptor blockade and GABA(A) receptor-positive modulation. Toxicol Sci (2012) 0.95
The enantiomer of progesterone acts as a molecular neuroprotectant after traumatic brain injury. Neuropharmacology (2006) 0.95
Molecular targets versus models for new antiepileptic drug discovery. Epilepsy Res (2006) 0.94
Characterization of seizures induced by acute and repeated exposure to tetramethylenedisulfotetramine. J Pharmacol Exp Ther (2012) 0.94
Anticonvulsant and proconvulsant actions of 2-deoxy-D-glucose. Epilepsia (2010) 0.94
Cholesterol tuning of BK ethanol response is enantioselective, and is a function of accompanying lipids. PLoS One (2011) 0.94
Treatment of early and late kainic acid-induced status epilepticus with the noncompetitive AMPA receptor antagonist GYKI 52466. Epilepsia (2009) 0.93